kabutan

Chordia Therapeutics, First Half Net Income Loss Narrows, Dec-Feb Net Income Loss Narrows

Tue Apr 14, 2026 3:30 pm JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results after the market closed on April 14th (15:30). The net loss (non-consolidated) for the cumulative second quarter of the fiscal year ending August 2026 (September 2025 to February 2026) was a reduced loss of 0.63 billion yen (compared to a loss of 0.97 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the March to August period (second half) is expected to expand to a loss of 1.32 billion yen (compared to a loss of 0.80 billion yen in the same period last year).

In the most recent three-month period, from December to February (2Q), the net loss improved to a deficit of 0.33 billion yen (compared to a loss of 0.36 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Sep - Feb, 2024 0 -996 -975 -976 -14.3 ー Apr 11, 2025 J-GAAP
Sep - Feb, 2025 0 -662 -632 -633 -9.0 ー Apr 14, 2026 J-GAAP
YoY － +33.5% +35.2% +35.1% +37.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2025 Guidance ー ー ー ー － 0 Oct 14, 2025 J-GAAP
Sep - Feb, 2025 Results 0 -662 -632 -633 -9.0 0 Apr 14, 2026 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2025 0 -793 -794 -809 -11.8 0 Oct 14, 2025 J-GAAP
Mar - Aug, 2026 Guidance ー -1,346 -1,326 -1,327 -18.0 0 Apr 14, 2026 J-GAAP
YoY － -69.7% -67.0% -64.0% -52.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 0 -1,789 -1,769 -1,785 -26.0 0 Oct 14, 2025 J-GAAP
Aug, 2026 Guidance ー -2,008 -1,958 -1,960 -26.6 0 Oct 14, 2025 J-GAAP
YoY － -12.2% -10.7% -9.8% -2.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2024 0 -372 -360 -360 -5.3 -Inf Apr 11, 2025 J-GAAP
Mar - May, 2025 0 -424 -422 -423 -6.2 -Inf Jul 14, 2025 J-GAAP
Jun - Aug, 2025 0 -369 -372 -386 -5.6 -Inf Oct 14, 2025 J-GAAP
Sep - Nov, 2025 0 -306 -294 -295 -4.2 -Inf Jan 14, 2026 J-GAAP
Dec - Feb, 2025 0 -356 -338 -338 -4.8 -Inf Apr 14, 2026 J-GAAP
YoY － +4.3% +6.1% +6.1% +9.5%

Related Articles